Hypericin

Hypericin
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2000-08-03 00:00:00
Sponsor HyBiopharma, Inc.;2500 York Road, Suite 100;Jamison, Pennsylvania, 18929